Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
Novelty
Mechanistic
Druggability
Priority
80%
Importance
85%
Tractability
75%
Market price
50%

Description

The abstract notes that current GBM treatments fail due to drug resistance, and quercetin shows promise, but the mechanistic basis for how quercetin might circumvent resistance pathways is not explained. Understanding these mechanisms is critical for rational drug development and combination therapies.

Gap type: unexplained_observation Source paper: Quercetin induces MGMT (None, None, PMID:37451151)